Rethinking Clinical Trials Grand Rounds: FDA Draft Guidance on Real-World Evidence

FDA Draft Guidance on Real-World Evidence

This NIH Collaboratory Rethinking Clinical Trials Grand Rounds features:

John Concato, MD, MS, MPH
Associate Director for Real-World Evidence Analytics
Office of Medical Policy (OMP)
Center for Drug Evaluation and Research (CDER)
Food and Drug Administration (FDA)

Learn More